Mental health benefits provider Spring Health announced Thursday it had raised $190 million in Series C funding, bringing the company’s valuation to $2 billion.

The round was led by Kinnevik with participation from the Guardian Life Insurance Company of America, Tiger Global, Northzone, RRE Ventures, Rethink Impact, Work-Bench, William K Warren Foundation, SemperVirens, Able Partners and True Capital Ventures.

Spring said the new investment brings the company’s total raise to $300 million. It plans to use the capital to expand its use among employers as well as grow partnerships with health plans.

"As a society, we face an unprecedented global mental health crisis that will long outlast the COVID-19 pandemic. Spring Health is supporting the mental health of millions of people around the world, and we're just getting started," April Koh, CEO of Spring Health, said in a statement. 

"As we enter this next phase of growth, we are thrilled to partner with Kinnevik, who has an exceptional track record in digital health and a deep commitment to sustainability, diversity, and positive long-term impact."

The latest funding builds on a $76 million Series B round from late 2020 and a $6 million seed investment from 2018. 

Digital surgery platform Caresyntax announced a $30 million extension to its Series C round, bringing the round’s total raise to $130 million.

The round was initially led by PFM Health Sciences, LP. Other investors include funds and accounts managed by BlackRock, ProAssurance, Harmonix, Relyens Group and IPF Partners.

The funding will go towards developing their platform and expanding data solutions for value-based healthcare providers.

"While surgery accounts for more than half of all hospital revenue, it is also unfortunately by far the biggest driver of post-treatment complications and mortality for patients, meaning health systems must use every tool at their disposal to manage risk in and around the OR," said Björn von Siemens, Caresyntax cofounder and chief business officer, in a statement.

"As more U.S. healthcare systems shift to value-based care arrangements, Caresyntax brings a proven model for reducing variability in surgical outcomes, and thereby driving big gains in financial performance."

The extension builds on its original $100 million Series C investment announced in late April. 

SafelyYou, maker of an AI-enabled tool for fall detection and prevention among dementia patients, closed a $19.5 million Series A financing round.

The round was led by Eclipse Ventures with participation from Founders Fund and existing investors DCVC and Foundation Capital.

SafelyYou said it will use the funds to scale its business in assisted living communities and nursing homes.

"We are excited to announce the closing of our Series A funding, led by Eclipse Ventures. This is another step toward achieving our vision for SafelyYou," founder and CEO George Netscher said in a statement.

"We launched our business to build a better world for those living with Alzheimer's and dementia, their families, and all those who care for them. We started with a focus on falls, but there are so many more needs. This is just the beginning for us, and we'll have many more product development announcements to share in the future."

New Zealand-based HeartLab, which makes AI-enabled software for analyzing echocardiograms, raised $2.45 million in seed funding, according to TechCrunch. 

The company said it will use the capital to expand to the U.S. by early next year. 

“To begin with we want to talk to small and medium clinics over in the U.S.,” CEO Will Hewitt told TechCrunch. 

“We’ve actually found that our products are most popular at those clinics because it replaces more software than at a larger clinic. At a larger clinic some of these bits of software they’ve already had to purchase, versus a smaller clinic, it’s stuff that they couldn’t access anyway.

"So when we get to the states, we want to start shipping mostly to those sorts of users while we work out how to best pitch our value proposition to the larger clinics.”

Santé Ventures, an early-stage investment firm for healthcare and life sciences companies, announced Thursday it had raised $260 million in its fourth fund.

Santé’s Fund IV secured investments from partners including the Pennsylvania Public School Employees' Retirement System and new institutional investors in Asia and Latin America.

Santé said the fund will invest in 15 to 25 companies that aim to improve health outcomes at a lower cost. 

"We have seen firsthand how events over the last 18 months have accelerated the adoption of technology in all facets of life, especially in healthcare," Kevin Lalande, cofounder and managing director of Santé Ventures, said in a statement.

"Our team's deep understanding of biological systems, machine learning, and health industry economics offers a truly differentiated investment platform. Santé's disciplined portfolio strategy is designed to engineer the luck out of fund-level venture capital returns by delivering superior performance independent of vintage year and the broader macroeconomic cycle, as demonstrated in the success of our track record over the last 15 years."